Biotech Industry News
A collection of Biotech latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
US to restrict investments in Chinese biotech firms
The U.S. Department of the Treasury has proposed to add biotechnology to its list of sensitive technologies on national security grounds, a move to restrict investment in the sector in rival countries, such as China. SCROLL TO CONTINUE WITH CONTENT…
Food Allergy Biotech Firm Lycia Surges 59% After Upsized IPO
Lycia Therapeutics Inc. shares leapt 32% in its trading debut, after the biotechnology firm focused on treatments for allergies and autoimmune diseases raised $317.5 million in an upsized US initial public offering. The company's shares pared early…
Trump administration proposes new curbs on China biotech deals
The Trump administration officially made biotechnology a national security concern late Thursday, proposing to subject certain deals with Chinese life sciences companies to new screening requirements or prohibit them altogether. Why it matters:…
Invesco Pharmaceuticals ETF vs. iShares Biotechnology ETF: Which Is the Better Buy?
Both the Invesco Pharmaceuticals ETF (PJP +1.23%) and the iShares Biotechnology ETF (IBB -0.95%)target specific niches of the healthcare sector, but their distinct approaches could appeal to different investors. While IBB casts a wide net across…
Angel Yeast Marks 40th Anniversary, Setting Its Sights on Becoming a Global Biotech Powerhouse
YICHANG, China, Oct. 23, 2026 /CNW/ -- Angel Yeast (SSE: 600298), one of the world's leading yeast manufacturers, has hosted the 2026 International Synthetic Biology Symposium and the Angel Group High-Quality Development Conference in Yichang, its…
Treasury proposes major restrictions to U.S. investment in Chinese biotech sector
WASHINGTON — The Trump administration late on Thursday proposed a rule that would severely restrict future U.S. investment in the Chinese biotech sector but still allow American drugmakers to buy the rights to medicines invented in the…
Bharat Biotech slashes malaria vaccine price on GAVI-backed pact with UNICEF
Vaccine maker Bharat Biotech International on Friday said it is reducing the price of malaria vaccine Mosqivac by about 40% following an agreement executed by UNICEF and financially backed by Gavi, the Vaccine Alliance. Enabled through an advance…
Bharat Biotech With Gavi and UNICEF Cuts Malaria Vaccine Price by 40%, Aims to Protect 1 Million More Children
Hyderabad: Bharat Biotech International Limited (BBIL) today announced equitable pricing with Gavi, the Vaccine Alliance, and UNICEF for the world's first malaria vaccine RTS,S/AS01, developed by GSK and now manufactured by BBIL under the brand…
Protecting the patent system that powers MD's biotech future
Maryland's Interstate 270 corridor is one of the country's top life sciences hubs, and it's partly because America's patent system still works the way it's supposed to. Strong intellectual property protections provide the certainty Maryland's…
Bharat Biotech announces equitable pricing for Malaria vaccine
Bharat Biotech International (BBIL) on Thursday announced equitable pricing with Gavi, the Vaccine Alliance, and UNICEF for the world's first malaria vaccine developed by GSK and now manufactured by BBIL under the brand name Mosqivac. The…
Bharat Biotech slashes price of malaria vaccine MOSQIVAC by 40%
Bharat Biotech on Friday announced a nearly 40 per cent reduction in the price of MOSQIVAC, the RTS,S/AS01 malaria vaccine. In a post on social media platform X, Bharat Biotech said the move will help protect another 1 million children and generate…
Best Biotech Stocks To Keep An Eye On - October 23rd
The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winning Moderna, Gemini Therapeutics, AbbVie, Gilead Sciences, and Amgen are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech…
Hyperliquid Prices Moderna Futures at $190.53 During U.S. Market Closure
Hyperliquid's xyz market quoted Moderna futures at $190.53 at 7 a.m. ET on Oct. 23, below the biotech company's latest regular-session share price. Yahoo Finance historical data show Moderna at $202.63 at the Oct. 22 close. The shares fell 17.57%…
Revered SF venue Bottom of the Hill will live on with a new owner
When it was announced earlier this year that Potrero Hill rock venue Bottom of the Hill would close at the end of 2026, the local music community let out a unanimous gasp. The 246-capacity venue has long been a breeding ground for Bay Area talent…
Warhound wants to engineer and clone military superdogs-can they do it?
A new biotechnology start-up wants to use gene-editing technology, cloning and advanced military technology to create a new dog optimized for combat. But does the science to back up its claims exist? And if so, can the company possibly deliver on…
Receive a Daily briefing on Biotech Industry News
Get Started